These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9631069)

  • 1. Phage diabody repertoires for selection of large numbers of bispecific antibody fragments.
    McGuinness BT; Walter G; FitzGerald K; Schuler P; Mahoney W; Duncan AR; Hoogenboom HR
    Nat Biotechnol; 1996 Sep; 14(9):1149-54. PubMed ID: 9631069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity.
    Nielsen UB; Adams GP; Weiner LM; Marks JD
    Cancer Res; 2000 Nov; 60(22):6434-40. PubMed ID: 11103810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics.
    Kipriyanov SM; Moldenhauer G; Schuhmacher J; Cochlovius B; Von der Lieth CW; Matys ER; Little M
    J Mol Biol; 1999 Oct; 293(1):41-56. PubMed ID: 10512714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody phage libraries for the next generation of tumor targeting radioimmunotherapeutics.
    DeNardo SJ; DeNardo GL; DeNardo DG; Xiong CY; Shi XB; Winthrop MD; Kroger LA; Carter P
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3213s-3218s. PubMed ID: 10541366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retargeting serum immunoglobulin with bispecific diabodies.
    Holliger P; Wing M; Pound JD; Bohlen H; Winter G
    Nat Biotechnol; 1997 Jul; 15(7):632-6. PubMed ID: 9219264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement recruitment using bispecific diabodies.
    Kontermann RE; Wing MG; Winter G
    Nat Biotechnol; 1997 Jul; 15(7):629-31. PubMed ID: 9219263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant bispecific antibodies for the targeting of adenoviruses to CEA-expressing tumour cells: a comparative analysis of bacterially expressed single-chain diabody and tandem scFv.
    Korn T; Nettelbeck DM; Völkel T; Müller R; Kontermann RE
    J Gene Med; 2004 Jun; 6(6):642-51. PubMed ID: 15170735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant approaches to IgG-like bispecific antibodies.
    Marvin JS; Zhu Z
    Acta Pharmacol Sin; 2005 Jun; 26(6):649-58. PubMed ID: 15916729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-HLA-DR/anti-DOTA diabody construction in a modular gene design platform: bispecific antibodies for pretargeted radioimmunotherapy.
    DeNardo DG; Xiong CY; Shi XB; DeNardo GL; DeNardo SJ
    Cancer Biother Radiopharm; 2001 Dec; 16(6):525-35. PubMed ID: 11789029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of murine phage antibody library and selection of ricin-specific single-chain antibodies.
    Gao X; Huang Y; Zhu S
    IUBMB Life; 1999 Nov; 48(5):513-7. PubMed ID: 10637767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro selection of bispecific diabody fragments using covalent bicistronic DNA display.
    Nakayama M; Komiya S; Fujiwara K; Horisawa K; Doi N
    Biochem Biophys Res Commun; 2016 Sep; 478(2):606-11. PubMed ID: 27473655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification and identification of a vector for making a large phage antibody library.
    Zhang GM; Chen YP; Guan YZ; Wang Y; An YQ
    Chin Med J (Engl); 2007 Nov; 120(22):2011-6. PubMed ID: 18067788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of large diversities of antiidiotypic antibody fragments by phage display.
    Goletz S; Christensen PA; Kristensen P; Blohm D; Tomlinson I; Winter G; Karsten U
    J Mol Biol; 2002 Feb; 315(5):1087-97. PubMed ID: 11827478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and purification of monospecific and bispecific recombinant antibody fragments derived from antibodies that block the CD80/CD86-CD28 costimulatory pathway.
    Dincq S; Bosman F; Buyse MA; Degrieck R; Celis L; de Boer M; Van Doorsselaere V; Sablon E
    Protein Expr Purif; 2001 Jun; 22(1):11-24. PubMed ID: 11388794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
    Wang X; Campoli M; Ko E; Luo W; Ferrone S
    J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humanization of the bispecific epidermal growth factor receptor x CD3 diabody and its efficacy as a potential clinical reagent.
    Asano R; Sone Y; Makabe K; Tsumoto K; Hayashi H; Katayose Y; Unno M; Kudo T; Kumagai I
    Clin Cancer Res; 2006 Jul; 12(13):4036-42. PubMed ID: 16818703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal construction of non-immune scFv phage display libraries from mouse bone marrow and spleen established to select specific scFvs efficiently binding to antigen.
    Okamoto T; Mukai Y; Yoshioka Y; Shibata H; Kawamura M; Yamamoto Y; Nakagawa S; Kamada H; Hayakawa T; Mayumi T; Tsutsumi Y
    Biochem Biophys Res Commun; 2004 Oct; 323(2):583-91. PubMed ID: 15369791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabody-based recombinant formats of humanized IgG-like bispecific antibody with effective retargeting of lymphocytes to tumor cells.
    Asano R; Kawaguchi H; Watanabe Y; Nakanishi T; Umetsu M; Hayashi H; Katayose Y; Unno M; Kudo T; Kumagai I
    J Immunother; 2008 Oct; 31(8):752-61. PubMed ID: 18779744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of bispecific antibodies: diabodies and tandem scFv.
    Hornig N; Färber-Schwarz A
    Methods Mol Biol; 2012; 907():713-27. PubMed ID: 22907382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A revival of bispecific antibodies.
    Kufer P; Lutterbüse R; Baeuerle PA
    Trends Biotechnol; 2004 May; 22(5):238-44. PubMed ID: 15109810
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.